Literature DB >> 4031498

The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.

D L Hamilos, H J Wedner.   

Abstract

The role of glutathione (GSH) in lectin-induced lymphocyte activation can be studied by quantitating lectin-induced nuclear size transformation in the presence of variable degrees of GSH depletion. Buthionine sulfoximine (BSO) inhibits intracellular GSH synthesis by inhibition of the enzyme gamma-glutamyl-cysteine synthetase. By combining endogenous GSH depletion in cell cultures with BSO-induced inhibition of GSH synthesis, lectin-induced lymphocyte activation can be studied at various concentrations of soluble intracellular GSH. With this approach, the percentage of lymphocytes undergoing a nuclear size transformation is minimally affected despite depletion of soluble intracellular GSH to 0.27 nmol/10(7) cells (PBL), which represents approximately 95% depletion of intracellular GSH. When soluble intracellular GSH is depleted to undetectable levels (less than 0.10 nmol/10(7) cells) there is a 10 to 12% reduction in the number of cell nuclei transformed. However, in all BSO-pretreated cultures the lectin-induced nuclear size transformation is intermediate between resting and blast-transformed lymphocytes, suggesting only partial (or aborted) activation. The partial activation response observed in BSO-pretreated cultures may be due to mobilization of the protein-bound pool of GSH, which is relatively resistant to depletion by BSO. That the inhibition of full blast transformation is truly due to GSH depletion was proven by experiments in which GSH was repleted exogenously and a full blast transformation was restored. The results of previous work in our laboratory had shown that the sulfhydryl-reactive agent 2-cyclohexene-1-one (2-CHX) was a potent inhibitor of activation at soluble intracellular GSH concentrations well above 0.27 nmol/10(7) PBL. In the present study, the dose-dependent inhibition of activation by 2-CHX was confirmed, but it was shown that the degree of inhibition caused by 2-CHX could be at least partially dissociated from the level of intracellular GSH present at the time of lectin addition and that the inhibitory potential of 2-CHX exceeded that of BSO at comparable levels of soluble intracellular GSH. Thus, the inhibitory properties of 2-CHX cannot be accounted for solely on the basis of GSH depletion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031498

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Age related changes in selenium and glutathione levels in different lobes of the rat prostate.

Authors:  John P Richie; Arunangshu Das; Ana M Calcagnotto; Cesar A Aliaga; Karam El-Bayoumy
Journal:  Exp Gerontol       Date:  2011-12-24       Impact factor: 4.032

2.  Novel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation.

Authors:  S Kubota; S Shetty; H Zhang; S Kitahara; R J Pomerantz
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

3.  In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes.

Authors:  Poojitha Matta; Stacy D Sherrod; Christina C Marasco; Daniel J Moore; John A McLean; Joern-Hendrik Weitkamp
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

4.  A functional trinucleotide repeat polymorphism in the 5'-untranslated region of the glutathione biosynthetic gene GCLC is associated with increased risk for lung and aerodigestive tract cancers.

Authors:  Sailendra N Nichenametla; Joshua E Muscat; Jason G Liao; Philip Lazarus; John P Richie
Journal:  Mol Carcinog       Date:  2012-05-18       Impact factor: 4.784

5.  Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.

Authors:  R Buhl; C Vogelmeier; M Critenden; R C Hubbard; R F Hoyt; E M Wilson; A M Cantin; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function.

Authors:  R Sinha; I Sinha; A Calcagnotto; N Trushin; J S Haley; T D Schell; J P Richie
Journal:  Eur J Clin Nutr       Date:  2017-08-30       Impact factor: 4.016

7.  HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Authors:  I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.

Authors:  Y J Kang; D Emery; M D Enger
Journal:  Cell Biol Toxicol       Date:  1991-07       Impact factor: 6.691

9.  Comparative study of intracellular glutathione content in rat lymphocyte cultures treated with 2-mercaptoethanol and interleukin-2.

Authors:  A Aidoo; L E Lyn-Cook; S M Morris; R L Kodell; D A Casciano
Journal:  Cell Biol Toxicol       Date:  1991-07       Impact factor: 6.691

10.  Blood iron, glutathione, and micronutrient levels and the risk of oral cancer.

Authors:  John P Richie; Wayne Kleinman; Patricia Marina; Patricia Abraham; Ernst L Wynder; Joshua E Muscat
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.